204 results
Page 3 of 11
6-K
EX-99.1
jmpxd gg5ehhbuv05map
5 Apr 22
Current report (foreign)
4:07pm
6-K
EX-99.1
7yiexx6sqjxlyquqbatm
1 Mar 22
BELLUS Health to Participate in the Cowen & Co. 42nd Annual Health Care Conference
7:00am
40-F
EX-99.2
n48mxli70ox1
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.3
cbdndcutcl8dlrud47yj
23 Feb 22
Annual report (Canada)
5:20pm
40-F
EX-99.1
5omob5
23 Feb 22
Annual report (Canada)
5:20pm
6-K
EX-99.1
hc8zg7fwb5gf25e90z
23 Feb 22
BELLUS Health Reports Year 2021 Financial Results and Business Highlights
4:01pm
6-K
EX-99.1
1z5um3
17 Dec 21
BELLUS Health Closes US$200 Million Public Offering of Common Shares in Canada and the United States
4:03pm
6-K
EX-99.1
153mlcyjumbu1gne
15 Dec 21
BELLUS Health Announces Pricing of US$200 Million Public Offering in Canada and the United States
5:15pm
SUPPL
nxgmqu5
15 Dec 21
Supplemental materials (foreign)
5:10pm
F-10
on2x1ja0cbmsit57r 1w
14 Dec 21
Registration of securities (Canada)
9:43am
SUPPL
7ocgr9 hypmgzpjty
13 Dec 21
Supplemental materials (foreign)
5:00pm
6-K
EX-99.1
qxipwit5 s7njefjhq
13 Dec 21
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
4:07pm
6-K
EX-99.2
dlud2tcl
13 Dec 21
BELLUS Health Announces the Launch of a Public Offering of Common Shares in Canada and the United States
4:07pm
6-K
EX-99.2
ddiltk0hhqwympox7lg
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
9oit8p1 347
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
EX-99.1
xcqvbzau autjx
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:19am
6-K
fda8libp
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.1
6xv7753iod
13 Dec 21
BELLUS Health Announces Positive Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
7:00am
6-K
EX-99.1
tfac3 k7ap
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm
6-K
EX-99.2
prewx4aa zf8vg
10 Nov 21
Condensed Consolidated Interim Financial Statements of
4:42pm